A gene that plays a role in the development of breast cancer to metastatic disease has been identified which may help to predict disease progression and serve as a target for ...
very interesting: "This is a platform that can deliver any gene of interest" http://www.medicalnewstoday.com/releases/304822.php [http://www.medicalnewstoda...
[http://www.bidnessetc.com/60761-heres-why-uniqure-nv-skyrocketed-today] UniQure NV (NASDAQ:QURE) stock is up more than 17% in early trading hours. The stock surged after the...
http://www.bidnessetc.com/60761-heres-why-uniqure-nv-skyrocketed-today/
Scientists exploit gene therapy to shrink tumors in mice with an aggressive form of breast cancer.
by Najeeb M. Halabi, Alejandra Martinez, Halema Al-Farsi, Eliane Mery, Laurence Puydenus, Pascal Pujol, Hanif G. Khalak, Cameron McLurcan, Gwenael Ferron, Denis Querleu, Iman ...
When GlaxoSmithKline veteran Amber Salzman started up Paris-based AAVLife and ramped up its first gene therapy program for Friedreich's ataxia, she started working early on wi...
The ectonucleotide pyrophosphatase/phosphodiesterase type 2, more commonly known as autotaxin (ATX), is an ecto-lysophospholipase D encoded by the human ENNP2 gene. ATX is exp...
The oncogenic transcription factor FOXM1 is overexpressed in the majority of human cancers, and it is a potential target for anticancer therapy. We identified proteasome inhib...
H. Stewart Parker is the former CEO of Seattle’s Targeted genetics, a pioneering gene therapy company that fizzled out after nearly 20 years but helped pave the way for a ne...
Treatment of Candida glabrata cystitis remains a therapeutic challenge, and an antifungal combination using flucytosine is one option. We describe two patients with refractory...
We have established a cell-free in vitro system to study human papillomavirus type 16 (HPV16) assembly, a poorly understood process. L1/L2 capsomers, obtained from the disasse...